Research ArticleClinical Studies
Radiotherapy Dose and Volume De-escalation in Ocular Adnexal Lymphoma
STEPHAN REHN, KHALED ELSAYAD, MICHAEL OERTEL, ANDREA BAEHR, NICOLE ETER, UWE HAVERKAMP, GEORG LENZ and HANS THEODOR EICH
Anticancer Research July 2020, 40 (7) 4041-4046; DOI: https://doi.org/10.21873/anticanres.14400
STEPHAN REHN
1Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany
KHALED ELSAYAD
1Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany
MICHAEL OERTEL
1Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany
ANDREA BAEHR
1Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany
NICOLE ETER
2Department of Ophthalmology, University Hospital Muenster, Muenster, Germany
UWE HAVERKAMP
1Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany
GEORG LENZ
3Department of Medicine A, University Hospital Muenster, Muenster, Germany
HANS THEODOR EICH
1Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany
In this issue
Radiotherapy Dose and Volume De-escalation in Ocular Adnexal Lymphoma
STEPHAN REHN, KHALED ELSAYAD, MICHAEL OERTEL, ANDREA BAEHR, NICOLE ETER, UWE HAVERKAMP, GEORG LENZ, HANS THEODOR EICH
Anticancer Research Jul 2020, 40 (7) 4041-4046; DOI: 10.21873/anticanres.14400
Jump to section
Related Articles
- No related articles found.